Prospective, Multicentre, Randomized, Controlled, Cross-over Study on the Safety and Performance of the Biologic Fusion Option of DialogiQ Compared to Haemodialysis Without Biologic Fusion in Hypotension Prone Patients on Maintenance Haemodialysis

NARecruitingINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

April 22, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

June 30, 2027

Conditions
Renal Dialysis
Interventions
DEVICE

BioLogic Fusion

Dialysis conducted with Dialog iQ dialysis machine either using the BioLogic Fusion option or not using it. This is only a biologic feedback system using blood pressure and residual blood volume as parameters to predict potential hypotensive episodes. If switched off, standard dialysis treatment happens, if switched on, the system tries to predict and prevent hypotensive episodes.

Trial Locations (1)

40138

RECRUITING

Policlinico S. Orsola - Malpighi - UOC Nefrologia, Dialisi e Ipertensione, Bologna

All Listed Sponsors
lead

B.Braun Avitum AG

INDUSTRY